Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Deep-Brain Stimulation Curbs Some Parkinson’s Symptoms, Not All – NEJM

This article was originally published in The Gray Sheet

Executive Summary

Relatively young patients may prove the best candidates for subthalamic nucleus stimulation therapy to treat Parkinson's disease, researchers write in the Nov. 13 issue of The New England Journal of Medicine

You may also be interested in...

Activa Deep-Brain Stimulation Coverage Includes Provider, Facility Criteria

CMS will monitor results of two long-term clinical studies evaluating "optimal targeting" for deep-brain stimulation to treat Parkinson's disease and essential tremor, following a positive national coverage determination

Perrigo Launches OTC Viagra Rival In UK

Perrigo is launching in the UK an OTC sildenafil generic to compete with Pfizer's erectile dysfunction drug Viagra Connect.

New Filings At The EMA

New medicines under evaluation at the European Medicines Agency.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts